- Global Pharma News & Resources

Press Releases - 2019-10-01

Date Title Company
01-Oct-2019 Johnson & Johnson Reaches Settlement Agreement with Two Ohio Counties Ahead of Upcoming Opioid Trial Johnson & Johnson
01-Oct-2019 Heron Therapeutics Appoints Stephen Davis to Board of Directors Heron Therapeutics, Inc.
01-Oct-2019 Gregory Robinson joins Nonprofit Biotech Odylia Therapeutics Advisory Board Odylia Therapeutics
01-Oct-2019 FDA informs patients, providers and manufacturers about potential cybersecurity vulnerabilities for connected medical devices and health care networks that use certain communication software U.S. Food and Drug Administration
01-Oct-2019 Genmed makes senior leadership team changes to build its international healthcare business and focus on NHS growth opportunities Genmed
01-Oct-2019 Ryvu Therapeutics and Selvita Announce Registration of Corporate Split by the National Court Register of Poland Selvita; Ryvu Therapeutics S.A.
01-Oct-2019 Registration is now open for SMi’s 14th Annual Parallel Trade Conference 2020 SMi Group
01-Oct-2019 Lonza to Host New Webinar – "Cell Culture Media: Why Go Serum-Free?" Lonza
01-Oct-2019 curasan launches product for the treatment of the spinal facet syndrome curasan AG
01-Oct-2019 CO.DON AG: Discussions on out-licensing and further cooperations CO.DON AG
01-Oct-2019 CapsCanada Expands Growth to New State-of-the-Art Facility CapsCanada
01-Oct-2019 Altavant Sciences Presents Data at ERS International Congress 2019 Demonstrating Strong Safety and Tolerability Profile of Rodatristat Ethyl Altavant Sciences
01-Oct-2019 CapsCanada Expands Growth to New State-of-the-Art Facility CapsCanada
01-Oct-2019 CTI BioPharma Begins Patient Enrollment in PACIFICA Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis Patients With Severe Thrombocytopenia CTI BioPharma Corp.
01-Oct-2019 Protagonist Therapeutics Announces Acceptance of Abstracts at the UEG Week 2019 Meeting and the ACG 2019 Annual Scientific Meeting Protagonist Therapeutics, Inc.
01-Oct-2019 Dr Mark Truesdale joins Solentim as new Chief Marketing Officer Solentim
01-Oct-2019 AstraZeneca selects N-SIDE Suite for Clinical Trials to optimize and monitor clinical trial supply chain N-SIDE
01-Oct-2019 Syneos Health Introduces New Book, Why We Resist: The Surprising Truths About Motivating Behavior Change Syneos Health
01-Oct-2019 Launches DocFinder Service, Announces SPEAR Physical and Occupational Therapy as Newest Subscriber